TD Asset Management
AGN

TD Asset Management’s Allergan Inc AGN Stock Holding History

TD Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-411,318
Closed -$87.4M – 1454
2014
Q4 		$87.4M Buy
411,318
+56,197
+16% +$11.2M 0.15% 128
2014
Q3 		$63.3M Buy
355,121
+33,929
+11% +$5.64M 0.11% 147
2014
Q2 		$54.4M Buy
321,192
+107,040
+50% +$16.7M 0.09% 170
2014
Q1 		$26.6M Buy
214,152
+51,040
+31% +$6.21M 0.05% 263
2013
Q4 		$18.1M Sell
163,112
-8,540
-5% -$816K 0.03% 326
2013
Q3 		$15.5M Sell
171,652
-34,868
-17% -$3.13M 0.03% 339
2013
Q2 		$17.4M Buy
+206,520
New +$21.4M 0.04% 302

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

TD Asset Management's AGN Position: Q1 2015 in Review

TD Asset Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 411,318 shares — an estimated $87.4M sold.

TD Asset Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $87.4M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • TD Asset Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • TD Asset Management sold 411,318 Allergan Inc shares in Q1 2015, an estimated $87.4M.
  • TD Asset Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • TD Asset Management's Allergan Inc position peaked at $87.4M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on TD Asset Management's 13F filing for Q1 2015, filed 28 Apr 2015.